NCT01311388

Unknown

Construction of the "Patient-Centered"Molecular Pathology Di...

Taipei Medical University WanFang Hospital Source

Compare

Other study identifiers

Sponsor study identifier

99049

Study Type

observational

Estimated enrollment

1,500

Locations

1 country

Sites

1

Timeline

Study Start

August 2010

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

December 2013

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

The investigators want to achieve the goal of diagnosis in early phase, accurate treatment and existence for a long period in order to screen in early phase, diagnose in clinical trial, choose treatment and evaluate prognosis of cancers by establishing molecular pathology tools.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 1,500 participants
Study completion date: December 2013
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
August 2010
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
March 6, 2011
Actual (reported)
First Posted
March 9, 2011
Actual (reported)
Study Completion
December 2013
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: March 9, 2011
Status Verified: March 2011
Last Update Submitted: March 8, 2011

Conditions

Cancer

Keywords

cancer

Eligibility Criteria

Age20 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

cancer patients

You may qualify if:

above 20 years old
all kinds of cancer patients

You may not qualify if:

under 20 years old
none cancer patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Taipei Medical University WanFang Hospital
Otherlead

Study Sites (1)

TMU-CECR

Taipei, Taiwan

MeSH Terms

Conditions

Neoplasms

Study Officials

Wen-Ta Chiu
TMU-CECR
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER

Study Record Dates

First Submitted

March 6, 2011

First Posted

March 9, 2011

Study Start

August 2010

Date type not reported

This date has not been verified as actual or estimated.

Study Completion

December 2013

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

NCT01376310

GSK1120212 Rollover Study

Phase 2Terminated

NCT01198119

Excision Limits of Oral Cavity Tumor by Narrow Band Imaging

Phase 2Terminated

NCT01162642

Green Tea Anticancer Mechanisms in Smokers

Not ApplicableCompleted

NCT01007695

Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a Pilot

Phase 1Terminated

NCT01317355

Multiple Symptoms in Cancer Patients a Cross Sectional Multi Center Study

Completed

NCT04208243

Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders

Not ApplicableCompleted

Last Updated

March 9, 2011

Record last verified: 2011-03

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01311388
Data provider: ClinicalTrials.gov
Source updated: 2011-03-09
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:22:35 UTC

Locations

TW(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Study Officials

Study Design

Study Record Dates

Source record

Locations